688580 伟思医疗
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)3.5718.3166.2678.6376.129
总资产报酬率 ROA (%)3.2657.4055.6247.8085.647
投入资产回报率 ROIC (%)3.5638.2216.1418.4445.984

边际利润分析
销售毛利率 (%)66.15766.18865.44867.72972.478
营业利润率 (%)66.35732.91927.87232.11532.478
息税前利润/营业总收入 (%)65.39832.75826.20528.56427.031
净利润/营业总收入 (%)58.06629.83925.48929.47929.173

收益指标分析
经营活动净收益/利润总额(%)44.61976.56866.39676.78370.470
价值变动净收益/利润总额(%)3.62511.24712.1446.41015.127
营业外收支净额/利润总额(%)0.0001.3651.5671.0461.307

偿债能力分析
流动比率 (X)9.6545.1786.0728.27310.207
速动比率 (X)9.3064.9825.8708.0109.938
资产负债率 (%)5.77011.31510.5979.9269.243
带息债务/全部投入资本 (%)0.1560.2161.9730.3060.834
股东权益/带息债务 (%)63,990.46546,282.9964,965.53232,005.58211,681.985
股东权益/负债合计 (%)1,633.110783.810843.674907.439981.920
利息保障倍数 (X)-68.217-53.131-12.414-7.343-4.599

营运能力分析
应收账款周转天数 (天)15.96316.43727.79422.48125.418
存货周转天数 (天)99.51893.126102.42590.206132.738